CDR Jessica Voqui is a pharmacist officer in the U.S. Public Health Service (USPHS) and serves as the Associate Director for Postmarket Regulatory Science in the Division of Anesthesiology, Addiction Medicine, and Pain Medicine (DAAP) within the Office of New Drugs in the U.S. Food and Drug Administration’s (FDA’s) Center for Drug Evaluation and Research. Cmdr. Voqui is the division-level expert responsible for technical oversight of postmarket regulatory science actions for drug safety in DAAP, including actions related to opioid analgesics and products used to treat opioid use disorder.

CDR Voqui earned her Doctor of Pharmacy degree from Virginia Commonwealth University School of Pharmacy; earned a Master of Science degree through the Pharmaceutical Outcomes and Policy Graduate Program at the University of Florida; and obtained the Regulatory Affairs Certification in 2022. Before joining her current division, she began her FDA career by serving in diverse positions across the Office of New Drugs, on the Clinical Outcome Assessments Staff and the Biomedical Informatics and Regulatory Review Science Team.